Apogee Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $764k | 19k | 39.73 |
| 2025-06-30 | $836k | 19k | 43.43 |
| 2025-03-31 | $845k | 23k | 37.36 |
| 2024-12-31 | $1.0M | 23k | 45.30 |
| 2024-09-30 | $1.2M | 21k | 58.74 |
| 2024-06-30 | $828k | 21k | 39.35 |
| 2023-12-31 | $297k | 11k | 27.94 |
| 2023-09-30 | $227k | 11k | 21.30 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors